ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
94,084.74
-0.66%
S&P 500
5,827.04
-1.54%
Dow Jones
41,938.45
-1.63%
US Dollar vs Yen
157.705
0.01%
Brent Oil
79.285
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Tarsus Pharmaceuticals Inc (TARS) 銘柄情報

Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals Inc (TARS)

NASDAQ
52.69
-2.55
(-4.62%)
終了 1月11日 6:00AM
15分遅延
53.00
0.31
(0.59%)
取引時間後: 7:52AM
15分遅延

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
53.00
買値
50.22
売値
57.50
出来高
804,436
51.935 日の範囲 54.38
20.0818 52 週間の範囲 57.14
時価総額
2.026B
前日終値
55.24
始値
54.185
時刻
6
@
53.45
最終取引時間
財務取引量
US$ 42,404,674
VWAP
52.7135
平均取引量 (3 か月)
766,955
発行済株式数
38,226,929
配当利回り
-
PER
-14.80
1 株当たり利益 (EPS)
-3.55
歳入
17.45M
純利益
-135.89M

Tarsus Pharmaceuticals Inc について

Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex ... Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. 詳細を表示

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
www.tarsusrx.com
本社
Dover, Delaware, USA
設立
-
Tarsus Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker TARS. The last closing price for Tarsus Pharmaceuticals was US$55.24. Over the last year, Tarsus Pharmaceuticals shares have traded in a share price range of US$ 20.0818 to US$ 57.14.

Tarsus Pharmaceuticals currently has 38,226,929 shares in issue. The market capitalisation of Tarsus Pharmaceuticals is US$2.11 billion. Tarsus Pharmaceuticals has a price to earnings ratio (PE ratio) of -14.80.

TARS 最新ニュース

その他のニュース

Form 8-K - Current report

2024年12月20日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年11月16日
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

2024年11月16日
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

2024年11月15日
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

2024年11月14日
Edgar (US Regulatory)

Form 8-K - Current report

2024年11月14日
Edgar (US Regulatory)

Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

Generated $48.1 million in XDEMVY® net product sales driven by more than 41,400 bottles delivered to patients in the third quarter Strengthened payer coverage highlighted by securing the two...

2024年11月14日
GlobeNewswire Inc.

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors

Humana CMO brings more than two decades of experience driving innovative, value-based initiatives designed to improve patient outcomes IRVINE, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Tarsus...

2024年11月13日
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

2024年11月9日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年11月7日
Edgar (US Regulatory)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-2.465-4.4442441179155.4655752.6104807255.68291802CS
423.921568627455157.1449.86566767254.39479695CS
1215.7342.205527233737.2757.1435.8476695547.81534443CS
2624.5786.422792824528.4357.1420.081871874037.71200843CS
5232.52158.789062520.4857.1420.081871385334.76687676CS
15630.64137.03041144922.3657.1410.800139264527.63759918CS
26034.7189.61748633918.363.6910.800129363727.89932092CS

TARS - Frequently Asked Questions (FAQ)

What is the current Tarsus Pharmaceuticals share price?
The current share price of Tarsus Pharmaceuticals is US$ 53.00
How many Tarsus Pharmaceuticals shares are in issue?
Tarsus Pharmaceuticals has 38,226,929 shares in issue
What is the market cap of Tarsus Pharmaceuticals?
The market capitalisation of Tarsus Pharmaceuticals is USD 2.11B
What is the 1 year trading range for Tarsus Pharmaceuticals share price?
Tarsus Pharmaceuticals has traded in the range of US$ 20.0818 to US$ 57.14 during the past year
What is the PE ratio of Tarsus Pharmaceuticals?
The price to earnings ratio of Tarsus Pharmaceuticals is -14.8
What is the cash to sales ratio of Tarsus Pharmaceuticals?
The cash to sales ratio of Tarsus Pharmaceuticals is 115.25
What is the reporting currency for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Tarsus Pharmaceuticals?
The latest annual turnover of Tarsus Pharmaceuticals is USD 17.45M
What is the latest annual profit for Tarsus Pharmaceuticals?
The latest annual profit of Tarsus Pharmaceuticals is USD -135.89M
What is the registered address of Tarsus Pharmaceuticals?
The registered address for Tarsus Pharmaceuticals is 3500 S DUPONT HWY, DOVER, DELAWARE, 19901
What is the Tarsus Pharmaceuticals website address?
The website address for Tarsus Pharmaceuticals is www.tarsusrx.com
Which industry sector does Tarsus Pharmaceuticals operate in?
Tarsus Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.7M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.69M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.56M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.45M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.69M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.83M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.31M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M

TARS Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
TARS
Tarsus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有